Showing results (431-440 of 529) with videos related to
Sort By:
Pageof 53
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 6, 2025
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registryTommaso Clemente, Mehdi Benlarbi, Rebecka Papaioannu Borjesson, et al.Vaccines|November 19, 2020
Attitudes and Perception of Healthcare Workers Concerning Influenza Vaccination during the 2019/2020 Season: A Survey of Sicilian University HospitalsClaudio Costantino, Caterina Ledda, Raffaele Squeri, et al.Acta Bio-Medica : Atenei Parmensis|July 24, 2020
Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigationRaffaele Squeri, Antonio Levita, Rosanna Intelisano, et al.AIDS (London, England)|February 1, 2023
Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIVMaria Mazzitelli, Mattia Trunfio, Ana Milinkovic, et al.The Journal of Antimicrobial Chemotherapy|July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral eraRebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.Vaccine|November 25, 2023
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipientsNicolás Ducasa, Paula Benencio, Ezequiel Mauro, et al.Cells|May 8, 2019
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4Nadia Marascio, Maria Mazzitelli, Grazia Pavia, et al.Le Infezioni in Medicina|June 13, 2017
Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection controlMariaconcetta Reale, Alessio Strazzulla, Angela Quirino, et al.Journal of Clinical Medicine|October 28, 2023
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 PneumoniaTeresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo, et al.AIDS Research and Human Retroviruses|October 1, 2020
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian CohortArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.Pageof 53